The affected product, which is packaged in vials and used for induction of anesthesia, was distributed to wholesalers and direct customers from September 2011 through February 2012.
The recall was caused by the potential for visible particles embedded in the glass to become dislodged into the solution. If this occurred, the matted could be injected into a patient and cause injuries.
More Articles on Recalls:
FDA Warns of Risk of Death From Codeine in Children Following Surgery
Covidien Initiates Voluntary Recall of Tracheostomy Tubes
St. Jude Medical Recalls Neurostimulation Device for Battery Issues
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
